According to the Tianyancha App, on July 27, Shanghai Shangshi Biomedical Industry Private Equity Fund Partnership was established. The executive partners are Shanghai Shangshi Capital Management Co., Ltd. and Shanghai Shangshi Biomedical Management Consulting Co., Ltd., with an investment amount of 1.5 billion yuan. The business scope is to use private equity funds to engage in equity investment, investment management, and asset management activities. According to partner information, the fund is co-funded by Shanghai SDIC's leading biomedical private equity fund partnership, Shanghai Pharmaceutical Group Co., Ltd., and Shanghai Junshi Biomedical Technology Co., Ltd.

According to the Tianyancha App, on July 27, Shanghai Shangshi Biomedical Industry Private Equity Fund Partnership was established. The executive partners are Shanghai Shangshi Capital Management Co., Ltd. and Shanghai Shangshi Biomedical Management Consulting Co., Ltd., with an investment amount of 1.5 billion yuan. The business scope is to use private equity funds to engage in equity investment, investment management, and asset management activities. According to partner information, the fund is co-funded by Shanghai SDIC's leading biomedical private equity fund partnership, Shanghai Pharmaceutical Group Co., Ltd., and Shanghai Junshi Biomedical Technology Co., Ltd.